WAP
OPNT

Wealthcare Advisory Partners’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Wealthcare Advisory Partners’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100
Closed -$1K – 1461
2020
Q1 		$1K Hold
100
– – ﹤0.01% 1456
2019
Q4 		$1K Hold
100
– – ﹤0.01% 1361
2019
Q3 		$2K Buy
+100
New +$1.39K ﹤0.01% 1254

Other funds holding OPNT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

Wealthcare Advisory Partners's OPNT Position: Q2 2020 in Review

Wealthcare Advisory Partners sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q2 2020, closing a stake of 100 shares — an estimated $1K sold.

Wealthcare Advisory Partners first reported a position in OPNT in Q3 2019 and held it in 3 quarters. The position peaked at $2K in Q3 2019. 30 funds tracked by Wall St. Rank hold OPNT as of Q2 2020.

  • Wealthcare Advisory Partners reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 100 Opiant Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $1K.
  • Wealthcare Advisory Partners first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
  • Wealthcare Advisory Partners's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q3 2019.
  • 30 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2020, filed 29 Jul 2020.